HUMORAL IMMUNITY IN AGING

被引：89

作者：

PAGANELLI, R

SCALA, E

QUINTI, I

ANSOTEGUI, IJ

机构：

[1] Department of Clinical Immunology, “La Sapienza” University, Roma

[2] Cattedra di Immunologia Clinica E Allergologia, Università “La Sapienza”, Roma, 00185

来源：

AGING-CLINICAL AND EXPERIMENTAL RESEARCH | 1994年 / 6卷 / 03期

关键词：

AGING; B LYMPHOCYTES; CYTOKINES; IMMUNOGLOBULINS;

D O I：

10.1007/BF03324229

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

The interactions between B and T lymphocytes, leading to the development of humoral responses, are reviewed with references to the changes occurring in aged people. Aging is perceived as a process of impairment of immune functions; it is known that T cells from aged subjects have a reduced ability to produce IL-2. However, other functions seem to be upregulated in elderly subjects; indeed, IL-1, IL-3, IL-4, IL-6 and TNF alpha production are increased both in aged mice and humans. These cytokines are known to control B cell differentiation, through isotype switch and Ig production. A significant increase in IgG subclasses and IgA is observed in sera of aged subjects. This contrasts with the significant decrease in circulating B lymphocytes. The impairment of primary responses to immunization, and other aspects of humoral immunity, including mucosal responses, autoantibody production and correlations with phenotypic markers of T and B cell subsets, are discussed.

引用

页码：143 / 150

页数：8

共 55 条

[11]

Snapper C.M., Mond J.J., Towards a comprehensive view of immunoglobulin class switching, Immunol. Today, 14, pp. 15-17, (1993)

[12]

Sutton B.J., Gould H.J., The human IgE network, Nature, 366, pp. 421-428, (1993)

[13]

Defrance T., Carayon P., Billian G., Guillemot J-C, Minty A., Caput D., Ferrara P., Interleukin 13 is a B cell stimulating factor, J. Exp. Med., 179, pp. 135-143, (1994)

[14]

Saxon A., Sidell N., Zhang K., B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation, Cell. Immunol., 144, pp. 169-181, (1992)

[15]

Radl J., Sepers J.M., Skvaril F., Morell A., Hijmans W., Immunoglobulin patterns in humans over 95 years of age, Clin. Exp. Immunol., 22, pp. 84-90, (1975)

[16]

Dworsky R., Paganini-Hill A., Arthur M., Parker J., Immune responses of healthy humans 83–104 years of age, J. Nat. Cancer Inst., 71, pp. 265-268, (1983)

[17]

Thompson J.S., Wekstein D.R., Rhoades J.L., Kirkpatrick C., Brown S.A., Roszman T., Straus R., Tietz N., The immune status of healthy centenarians, J. Am. Geriatr. Soc., 32, pp. 274-281, (1984)

[18]

Rabinowich H., Goses Y., Reshef T., Klajman A., Interleukin-2 production and activity in aged humans, Mech. Ageing Dev., 32, pp. 213-226, (1985)

[19]

Ligthart G.J., Corberand J.X., Fournier C., Garanaud P., Hijmans W., Kennes B., Muller-Hermelink H.K., Steinmann G.G., Admission criteria for immunogerontological studies in man: the SENIEUR protocol, Mech. Ageing Dev., 28, pp. 47-55, (1984)

[20]

Paganelli R., Quinti I., Fagiolo U., Cossarizza A., Ortolani C., Guerra E., Sansoni P., Pucillo L.P., Scala E., Cozzi E., Bertollo L., Monti D., Franceschi C., Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population, Clin. Exp. Immunol., 90, pp. 351-354, (1990)

← 1 2 3 4 5 6 →